Epidemiologic Study Findings Show Over 400 Percent Increase in Gout Patient Hospitalizations Since 1993
14 juin 2017 09h00 HE
|
Horizon Pharma plc
MADRID, Spain, June 14, 2017 (GLOBE NEWSWIRE) -- Results from a new study to be presented tomorrow at the Annual European Congress of Rheumatology (EULAR) 2017 show a 410 percent increase in...
Selecta Biosciences Announces Upcoming Clinical Presentations
06 juin 2017 08h00 HE
|
Selecta Biosciences
WATERTOWN, Mass., June 06, 2017 (GLOBE NEWSWIRE) -- Selecta Biosciences, Inc. (NASDAQ:SELB), a clinical-stage biopharmaceutical company focused on unlocking the full potential of biologic therapies...
ProteoThera, Inc. Receives Allowance for a Broad U.S. Patent Covering Matrix-Binding Technology Platform
09 mai 2016 08h00 HE
|
ProteoThera, Inc.
Newton, MA, May 09, 2016 (GLOBE NEWSWIRE) -- ProteoThera, Inc., a biotechnology company with a platform technology for local, targeted drug delivery, announced today that a notice of allowance has...
CymaBay Therapeutics Announces Successful Completion of End-of-Phase 2 Discussions With FDA for Arhalofenate
20 janv. 2016 08h00 HE
|
CymaBay Therapeutics, Inc.
NEWARK, Calif., Jan. 20, 2016 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (NASDAQ:CBAY), a clinical-stage biopharmaceutical company developing therapies to treat metabolic diseases with high...

Gout & Uric Acid Education Society Calls New Guidelines on Gout Management an Important Milestone, Publishes Response for Physicians and Patients
31 oct. 2012 09h00 HE
|
Gout & Uric Acid Education Society
PITTSBURGH, Oct. 31, 2012 (GLOBE NEWSWIRE) -- As the American College of Rheumatology prepares for its annual meeting in November, the Gout & Uric Acid Education Society has responded to recently...